https://www.sciencedaily.com/news/mind_brain/caregiving/ Make informed caregiving and home health care choices for your loved ones. Read the latest research for caregivers on caregiving. en-us Sat, 07 Mar 2026 06:16:29 EST Sat, 07 Mar 2026 06:16:29 EST 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/mind_brain/caregiving/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/03/260303145730.htm A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments. Tue, 03 Mar 2026 21:38:45 EST https://www.sciencedaily.com/releases/2026/03/260303145730.htm https://www.sciencedaily.com/releases/2026/02/260228093505.htm Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes that spread unevenly across the brain and extend beyond amyloid plaques. Key memory regions showed major shifts in cholesterol and energy-related molecules. The findings hint that Alzheimer’s is a whole-brain metabolic disruption—not just a protein problem. Sun, 01 Mar 2026 10:16:01 EST https://www.sciencedaily.com/releases/2026/02/260228093505.htm https://www.sciencedaily.com/releases/2026/02/260224023159.htm Subtle changes in brain blood flow and oxygen use are closely linked to hallmark signs of Alzheimer’s, including amyloid plaques and memory-related brain shrinkage. Simple, noninvasive scans may one day help spot risk earlier—by looking at the brain’s vascular health, not just its plaques. Tue, 24 Feb 2026 10:21:58 EST https://www.sciencedaily.com/releases/2026/02/260224023159.htm https://www.sciencedaily.com/releases/2026/02/260222085203.htm Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care. Mon, 23 Feb 2026 06:46:07 EST https://www.sciencedaily.com/releases/2026/02/260222085203.htm https://www.sciencedaily.com/releases/2026/02/260221000321.htm A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline. Sat, 21 Feb 2026 00:43:23 EST https://www.sciencedaily.com/releases/2026/02/260221000321.htm https://www.sciencedaily.com/releases/2026/02/260220010836.htm Breathing polluted air may do more than harm your lungs — it could also increase your risk of Alzheimer’s disease. In a sweeping study of nearly 28 million older Americans, researchers found that long term exposure to fine particle air pollution was linked to a higher likelihood of developing Alzheimer’s. The connection appeared to stem largely from pollution’s direct effects on the brain, rather than through related health conditions like hypertension or depression. Fri, 20 Feb 2026 01:47:05 EST https://www.sciencedaily.com/releases/2026/02/260220010836.htm https://www.sciencedaily.com/releases/2026/02/260219040820.htm A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replace what’s been lost. Fri, 20 Feb 2026 04:03:58 EST https://www.sciencedaily.com/releases/2026/02/260219040820.htm https://www.sciencedaily.com/releases/2026/02/260219040752.htm Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies. Fri, 20 Feb 2026 10:19:43 EST https://www.sciencedaily.com/releases/2026/02/260219040752.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260215225555.htm Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects. Tue, 17 Feb 2026 05:30:08 EST https://www.sciencedaily.com/releases/2026/02/260215225555.htm https://www.sciencedaily.com/releases/2026/02/260215084954.htm Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team uncovered cause-and-effect relationships between genes across six major brain cell types, revealing which genes are truly driving harmful changes. The most dramatic disruptions were found in excitatory neurons, where thousands of genetic interactions appear to be extensively rewired as the disease progresses. Sun, 15 Feb 2026 09:15:19 EST https://www.sciencedaily.com/releases/2026/02/260215084954.htm https://www.sciencedaily.com/releases/2026/02/260212234218.htm Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that special support cells called astrocytes—located far from the actual injury—spring into action after damage. These “lesion-remote astrocytes” send out a protein signal, CCN1, that reprograms immune cells to efficiently clean up fatty nerve debris. Fri, 13 Feb 2026 08:47:43 EST https://www.sciencedaily.com/releases/2026/02/260212234218.htm https://www.sciencedaily.com/releases/2026/02/260211073023.htm A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease, even two decades later. Participants who received the boosted speed training had a 25% lower dementia risk compared to those who received no training, making it the only intervention in the trial to show such a lasting protective effect. Wed, 11 Feb 2026 22:15:24 EST https://www.sciencedaily.com/releases/2026/02/260211073023.htm https://www.sciencedaily.com/releases/2026/02/260210040623.htm Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains elevated long afterward, unlike in other chronic illnesses. This suggests depression may reflect early brain changes rather than emotional distress alone. Wed, 11 Feb 2026 06:57:31 EST https://www.sciencedaily.com/releases/2026/02/260210040623.htm https://www.sciencedaily.com/releases/2026/02/260209064310.htm A long-term study found that women who closely followed a Mediterranean diet had a much lower risk of stroke. The strongest benefits were seen in women who ate more plant-based foods, fish, and olive oil while cutting back on red meat and saturated fats. Their risk dropped across all major stroke types, including bleeding strokes, which are less commonly studied. The findings suggest diet may be a powerful but overlooked factor in stroke prevention. Mon, 09 Feb 2026 06:54:46 EST https://www.sciencedaily.com/releases/2026/02/260209064310.htm https://www.sciencedaily.com/releases/2026/02/260208203013.htm A new international study points to a specific brain network as the core driver of Parkinson’s disease. Scientists found that this network becomes overly connected, disrupting not just movement but also thinking and other bodily functions. When researchers targeted it with non-invasive brain stimulation, patients showed much stronger symptom improvement than with conventional stimulation. The discovery could reshape how Parkinson’s is diagnosed and treated. Sun, 08 Feb 2026 20:37:23 EST https://www.sciencedaily.com/releases/2026/02/260208203013.htm https://www.sciencedaily.com/releases/2026/02/260206012213.htm Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease. Using advanced computer modeling, researchers discovered that beta-sitosterol—a natural plant compound—strongly interacts with two key enzymes involved in memory loss and cognitive decline. The compound showed stability, strong binding, and favorable safety indicators, making it a standout candidate for future drug development. Sun, 08 Feb 2026 07:57:41 EST https://www.sciencedaily.com/releases/2026/02/260206012213.htm https://www.sciencedaily.com/releases/2026/02/260206012203.htm Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The early-stage clinical trial involves implanting lab-grown dopamine-producing cells directly into a key movement-control region of the brain, with the hope of slowing disease progression and improving motor function. Fri, 06 Feb 2026 06:57:35 EST https://www.sciencedaily.com/releases/2026/02/260206012203.htm https://www.sciencedaily.com/releases/2026/02/260203030554.htm Scientists still don’t know how the brain turns physical activity into thoughts, feelings, and awareness—but a powerful new tool may help crack the mystery. Researchers at MIT are exploring transcranial focused ultrasound, a noninvasive technology that can precisely stimulate deep regions of the brain that were previously off-limits. In a new “roadmap” paper, they explain how this method could finally let scientists test cause-and-effect in consciousness research, not just observe correlations. Wed, 04 Feb 2026 07:42:40 EST https://www.sciencedaily.com/releases/2026/02/260203030554.htm https://www.sciencedaily.com/releases/2026/02/260201062459.htm When the brain rests, it usually replays recent experiences to strengthen memory. Scientists found that in Alzheimer’s-like mice, this replay still occurs — but the signals are jumbled and poorly coordinated. As a result, memory-supporting brain cells lose their stability, and the animals struggle to remember where they’ve been. Sun, 01 Feb 2026 10:41:29 EST https://www.sciencedaily.com/releases/2026/02/260201062459.htm https://www.sciencedaily.com/releases/2026/02/260201062457.htm Middle age is becoming a tougher chapter for many Americans, especially those born in the 1960s and early 1970s. Compared with earlier generations, they report more loneliness and depression, along with weaker physical strength and declining memory. These troubling trends stand out internationally, as similar declines are largely absent in other wealthy nations, particularly in Nordic Europe, where midlife well-being has improved. Sun, 01 Feb 2026 10:25:53 EST https://www.sciencedaily.com/releases/2026/02/260201062457.htm https://www.sciencedaily.com/releases/2026/01/260129080424.htm Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in the blood tied to how cells handle stress and repair DNA, the team identified a brief early window when Parkinson’s quietly leaves a measurable fingerprint. Thu, 29 Jan 2026 09:26:14 EST https://www.sciencedaily.com/releases/2026/01/260129080424.htm https://www.sciencedaily.com/releases/2026/01/260125083413.htm Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same receptor, triggering synapse loss. Surprisingly, neurons aren’t passive victims—they actively respond to these signals. Targeting this receptor could offer a new way to protect memory beyond current amyloid-focused drugs. Mon, 26 Jan 2026 03:08:27 EST https://www.sciencedaily.com/releases/2026/01/260125083413.htm https://www.sciencedaily.com/releases/2026/01/260124073920.htm A large, decades-long study suggests that signs of ADHD in childhood may have consequences that extend well beyond school and behavior. Researchers followed nearly 11,000 people from childhood into midlife and found that those with strong ADHD traits at age 10 were more likely to experience multiple physical health problems and health-related disability by their mid-40s. Sat, 24 Jan 2026 07:39:20 EST https://www.sciencedaily.com/releases/2026/01/260124073920.htm https://www.sciencedaily.com/releases/2026/01/260124003829.htm Researchers have found that a natural aging-related molecule can repair key memory processes affected by Alzheimer’s disease. The compound improves communication between brain cells and restores early memory abilities that typically fade first. Because it already exists in the body and declines with age, boosting it may offer a safer way to protect the brain. The discovery hints at a new strategy for slowing cognitive ageing before severe damage sets in. Sun, 25 Jan 2026 02:17:02 EST https://www.sciencedaily.com/releases/2026/01/260124003829.htm https://www.sciencedaily.com/releases/2026/01/260122093435.htm A new study reveals that super agers over 80 have a distinct genetic edge. They are much less likely to carry the gene most associated with Alzheimer’s risk, even when compared with other healthy seniors. Researchers also found higher levels of a protective gene variant in this group. Together, the findings help explain why some people age with remarkably youthful minds. Thu, 22 Jan 2026 09:41:30 EST https://www.sciencedaily.com/releases/2026/01/260122093435.htm https://www.sciencedaily.com/releases/2026/01/260122073623.htm Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even including a common version once considered neutral. The discovery reshapes how scientists think about risk and prevention. It also highlights a major opportunity for new treatments aimed at a single biological pathway. Fri, 23 Jan 2026 10:16:38 EST https://www.sciencedaily.com/releases/2026/01/260122073623.htm https://www.sciencedaily.com/releases/2026/01/260120095111.htm Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy systems. They designed a new treatment that intercepts this harmful process, protecting brain cells and restoring their function. In lab and animal models, the approach improved movement and cognitive performance while reducing inflammation. The findings point toward a new generation of Parkinson’s therapies aimed at the root cause, not just the symptoms. Tue, 20 Jan 2026 10:08:47 EST https://www.sciencedaily.com/releases/2026/01/260120095111.htm https://www.sciencedaily.com/releases/2026/01/260118233547.htm Cannabis-based medicines have been widely promoted as a potential answer for people living with chronic nerve pain—but a major new review finds the evidence just isn’t there yet. After analyzing more than 20 clinical trials involving over 2,100 adults, researchers found no strong proof that cannabis products outperform placebos in relieving neuropathic pain. Even when small improvements were reported, especially with THC-CBD combinations, they weren’t large enough to make a real difference in daily life. Mon, 19 Jan 2026 00:11:47 EST https://www.sciencedaily.com/releases/2026/01/260118233547.htm https://www.sciencedaily.com/releases/2026/01/260116035348.htm Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN was disabled, tau vanished from neurons and brain cells remained healthy. The findings challenge long-held assumptions about tau’s necessity and highlight a promising new path for fighting Alzheimer’s and brain aging. Scientists now believe OTULIN may act as a master switch for inflammation and age-related brain decline. Fri, 16 Jan 2026 03:53:48 EST https://www.sciencedaily.com/releases/2026/01/260116035348.htm https://www.sciencedaily.com/releases/2026/01/260112001041.htm Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely to develop Alzheimer’s disease. Using a noninvasive brain scanning technique and a custom analysis tool, they detected subtle changes in electrical signals tied to memory processing years before diagnosis. The findings point to a new way of spotting Alzheimer’s early—by listening directly to how neurons behave. Mon, 12 Jan 2026 09:24:19 EST https://www.sciencedaily.com/releases/2026/01/260112001041.htm https://www.sciencedaily.com/releases/2026/01/260106001916.htm A familiar mouth bacterium best known for causing cavities may also be quietly influencing the brain. Scientists found that when this microbe settles in the gut, it produces compounds that can travel through the bloodstream and harm neurons involved in movement. In animal studies, this process triggered inflammation, motor problems, and brain changes linked to Parkinson’s disease. The findings hint that protecting oral and gut health could help protect the brain as well. Tue, 06 Jan 2026 22:25:32 EST https://www.sciencedaily.com/releases/2026/01/260106001916.htm https://www.sciencedaily.com/releases/2025/12/251228074455.htm Feeling warm or cold doesn’t just register on the skin—it changes how connected we feel to our own bodies. Research shows that temperature sensations help shape body ownership, emotional regulation, and mental well-being. Disruptions in thermal perception are linked to conditions like depression, trauma, and stroke-related body disconnect. These insights could lead to new sensory-based mental health treatments and more lifelike prosthetics. Sun, 04 Jan 2026 18:17:24 EST https://www.sciencedaily.com/releases/2025/12/251228074455.htm https://www.sciencedaily.com/releases/2025/12/251228074451.htm Tiny lab-grown brains are offering an unprecedented look at how schizophrenia and bipolar disorder disrupt neural activity. Researchers found distinct electrical firing patterns that could identify these conditions with high accuracy. The discovery opens the door to more precise diagnoses and personalized drug testing. Instead of guessing medications, doctors may one day see what works before treating the patient. Sun, 28 Dec 2025 07:44:51 EST https://www.sciencedaily.com/releases/2025/12/251228074451.htm https://www.sciencedaily.com/releases/2025/12/251228020016.htm Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, easily seen on standard MRI scans, are tied to toxic protein buildup linked to memory loss and cognitive decline. In some cases, they may signal Alzheimer’s earlier than other commonly used brain markers. This could help physicians detect the disease earlier, before irreversible damage sets in. Sat, 03 Jan 2026 00:45:11 EST https://www.sciencedaily.com/releases/2025/12/251228020016.htm https://www.sciencedaily.com/releases/2025/12/251227082722.htm A major new review has put hundreds of alternative autism treatments under the microscope—and most didn’t hold up. Scientists analyzed decades of research and found little reliable evidence that popular approaches like probiotics, acupuncture, or music therapy truly work. Alarmingly, safety was often ignored, with many treatments never properly evaluated for side effects. The researchers stress that looking at the full body of evidence matters far more than trusting a single hopeful study. Sun, 28 Dec 2025 01:32:17 EST https://www.sciencedaily.com/releases/2025/12/251227082722.htm https://www.sciencedaily.com/releases/2025/12/251227004153.htm Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines. In brain tissue from more than 200 donors, the gene ADAMTS2 was significantly more active in people with Alzheimer’s than in those without it. Even more surprising, this same gene topped the list in an independent study of White individuals. The discovery hints at a common biological pathway behind Alzheimer’s and opens the door to new treatment strategies. Thu, 01 Jan 2026 11:23:26 EST https://www.sciencedaily.com/releases/2025/12/251227004153.htm https://www.sciencedaily.com/releases/2025/12/251225031247.htm A new study suggests that dementia may be driven in part by faulty blood flow in the brain. Researchers found that losing a key lipid causes blood vessels to become overactive, disrupting circulation and starving brain tissue. When the missing molecule was restored, normal blood flow returned. This discovery opens the door to new treatments aimed at fixing vascular problems in dementia. Thu, 25 Dec 2025 03:42:52 EST https://www.sciencedaily.com/releases/2025/12/251225031247.htm https://www.sciencedaily.com/releases/2025/12/251224032354.htm Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and restoring that balance can reverse damage, even in advanced cases. In mouse models, treatment repaired brain pathology, restored cognitive function, and normalized Alzheimer’s biomarkers. The results offer fresh hope that recovery may be possible. Wed, 24 Dec 2025 10:14:26 EST https://www.sciencedaily.com/releases/2025/12/251224032354.htm https://www.sciencedaily.com/releases/2025/12/251224015651.htm Cannabis products with higher THC levels may slightly reduce chronic pain, particularly nerve pain, according to a review of multiple clinical trials. The improvement was small and short-lived, while side effects were more common. Products with little or no THC, including CBD-only formulations, showed no clear benefit. Researchers say more long-term studies are needed. Tue, 30 Dec 2025 20:44:59 EST https://www.sciencedaily.com/releases/2025/12/251224015651.htm https://www.sciencedaily.com/releases/2025/12/251222080119.htm New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimer’s is prevented and treated. Mon, 22 Dec 2025 08:11:02 EST https://www.sciencedaily.com/releases/2025/12/251222080119.htm https://www.sciencedaily.com/releases/2025/12/251221043225.htm A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly enables movement in the background, much like oil in an engine. When scientists manipulated dopamine during movement, nothing changed—but restoring baseline dopamine levels made a big difference. The finding could reshape how Parkinson’s disease is treated. Mon, 22 Dec 2025 01:38:31 EST https://www.sciencedaily.com/releases/2025/12/251221043225.htm https://www.sciencedaily.com/releases/2025/12/251219093315.htm Researchers have revealed that so-called “junk DNA” contains powerful switches that help control brain cells linked to Alzheimer’s disease. By experimentally testing nearly 1,000 DNA switches in human astrocytes, scientists identified around 150 that truly influence gene activity—many tied to known Alzheimer’s risk genes. The findings help explain why many disease-linked genetic changes sit outside genes themselves. The resulting dataset is now being used to train AI systems to predict gene control more accurately. Fri, 19 Dec 2025 11:03:19 EST https://www.sciencedaily.com/releases/2025/12/251219093315.htm https://www.sciencedaily.com/releases/2025/12/251219030500.htm After injury, the visual system can recover by growing new neural connections rather than replacing lost cells. Researchers found that surviving eye cells formed extra branches that restored communication with the brain. These new pathways worked much like the originals. The repair process, however, was slower or incomplete in females, pointing to important biological differences in recovery. Fri, 19 Dec 2025 04:07:42 EST https://www.sciencedaily.com/releases/2025/12/251219030500.htm https://www.sciencedaily.com/releases/2025/12/251216081943.htm Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the blood called microvesicles, researchers may soon be able to gather brain-specific information without invasive procedures. If successful, this approach could transform Alzheimer’s diagnosis, monitoring, and even prevention, much like how doctors manage heart disease today. Wed, 17 Dec 2025 06:15:10 EST https://www.sciencedaily.com/releases/2025/12/251216081943.htm https://www.sciencedaily.com/releases/2025/12/251215084209.htm Consciousness evolved in stages, starting with basic survival responses like pain and alarm, then expanding into focused awareness and self-reflection. These layers help organisms avoid danger, learn from the environment, and coordinate socially. Surprisingly, birds show many of these same traits, from subjective perception to basic self-awareness. This suggests consciousness is far older and more widespread than once believed. Mon, 15 Dec 2025 10:29:52 EST https://www.sciencedaily.com/releases/2025/12/251215084209.htm https://www.sciencedaily.com/releases/2025/12/251214100933.htm New research shows that your brain’s “true age” can shift dramatically depending on how you live, with optimism, restorative sleep, stress management, and strong social support acting like powerful anti-aging tools. Using advanced MRI-based brain-age estimates, scientists found that people with multiple healthy lifestyle factors had brains up to eight years younger than expected — even among those living with chronic pain. Mon, 15 Dec 2025 08:26:34 EST https://www.sciencedaily.com/releases/2025/12/251214100933.htm https://www.sciencedaily.com/releases/2025/12/251210092019.htm Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster increases in proteins linked to neurodegeneration and amyloid buildup. Surprisingly, blood tests detected these changes earlier than PET scans. The results point to obesity as a major, modifiable contributor to Alzheimer’s progression. Wed, 10 Dec 2025 12:23:51 EST https://www.sciencedaily.com/releases/2025/12/251210092019.htm https://www.sciencedaily.com/releases/2025/12/251205045845.htm A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a higher overall risk of dementia. For those who already have elevated biomarkers, kidney problems may speed up when symptoms appear. The findings show that kidney health can change how Alzheimer’s blood tests are read. Doctors may need to consider both organs to get a clearer picture. Fri, 05 Dec 2025 05:19:42 EST https://www.sciencedaily.com/releases/2025/12/251205045845.htm https://www.sciencedaily.com/releases/2025/12/251202052213.htm Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to standard medications. The meta-analysis found rapid improvements after a single dose and more sustained benefits after repeated treatments. Side effects were generally mild and brief, though researchers stress the need for larger, longer-term studies. Tue, 02 Dec 2025 10:00:17 EST https://www.sciencedaily.com/releases/2025/12/251202052213.htm https://www.sciencedaily.com/releases/2025/12/251201085855.htm A high-speed “zap-and-freeze” method is giving scientists their clearest view yet of how brain cells send messages. By freezing tissue at the instant a signal fires, researchers revealed how synaptic vesicles behave in both mouse and human neurons. These insights could help explain why most Parkinson’s cases emerge without inherited genetic changes. The technique may also point to promising new research paths for therapy development. Mon, 01 Dec 2025 09:33:21 EST https://www.sciencedaily.com/releases/2025/12/251201085855.htm https://www.sciencedaily.com/releases/2025/11/251127010322.htm A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lower odds of developing the condition. Researchers believe that repeated dips in oxygen during sleep may strain neurons over time. The results suggest that better sleep might help protect the brain. Thu, 27 Nov 2025 01:10:17 EST https://www.sciencedaily.com/releases/2025/11/251127010322.htm https://www.sciencedaily.com/releases/2025/11/251127010319.htm Scientists studying young adults with obesity discovered early indicators of brain stress that resemble patterns seen in cognitive impairment. The group showed higher inflammation, signs of liver strain and elevated neurofilament light chain, a marker of neuron injury. Low choline levels appeared closely tied to these changes. The results hint that early metabolic disruptions may quietly influence the brain long before symptoms emerge. Thu, 27 Nov 2025 02:45:12 EST https://www.sciencedaily.com/releases/2025/11/251127010319.htm https://www.sciencedaily.com/releases/2025/11/251126095023.htm Spermine, a small but powerful molecule in the body, helps neutralize harmful protein accumulations linked to Alzheimer’s and Parkinson’s. It encourages these misfolded proteins to gather into manageable clumps that cells can more efficiently dispose of through autophagy. Experiments in nematodes show that spermine also enhances longevity and cellular energy production. These insights open the door to targeted therapies powered by polyamines and advanced AI-driven molecular design. Thu, 27 Nov 2025 07:35:52 EST https://www.sciencedaily.com/releases/2025/11/251126095023.htm https://www.sciencedaily.com/releases/2025/11/251124094328.htm Scientists have found that a mutation tied to Alzheimer’s disrupts the production and quality of exosomes—tiny cell-made communication packets. Cells with the defective SORLA protein generate fewer exosomes and ones far less able to support nearby brain cells. This weakness may be a key driver of Alzheimer’s development. The research points to new treatment strategies that enhance or restore exosome function. Mon, 24 Nov 2025 09:43:28 EST https://www.sciencedaily.com/releases/2025/11/251124094328.htm https://www.sciencedaily.com/releases/2025/11/251123085557.htm Researchers have uncovered a surprising way the brain switches pain on, revealing that neurons can release an enzyme outside the cell that activates pain signals without disrupting normal movement or sensation. This enzyme, called VLK, modifies nearby proteins in a way that intensifies pain and strengthens connections tied to learning and memory. Removing VLK in mice dramatically reduced post-surgery pain while leaving normal function untouched, offering a promising path toward safer, more targeted pain treatments. Sun, 23 Nov 2025 11:33:03 EST https://www.sciencedaily.com/releases/2025/11/251123085557.htm https://www.sciencedaily.com/releases/2025/11/251123085550.htm Researchers discovered that raising the protein Sox9 can help the brain’s astrocytes clear out toxic plaque buildup linked to Alzheimer’s. In mouse models that already showed memory problems, activating these cells improved cognitive performance. The treatment also reduced plaque levels over time. The work points toward a natural, cell-based way to slow Alzheimer’s decline. Sun, 23 Nov 2025 09:23:57 EST https://www.sciencedaily.com/releases/2025/11/251123085550.htm https://www.sciencedaily.com/releases/2025/11/251122044335.htm Scientists discovered that lowering a specific molecule helps microglia switch into a protective state that quiets brain inflammation in Alzheimer’s. A small group of these cells seems to have an outsized ability to keep the brain healthier. When a key signal is removed from them, Alzheimer’s symptoms worsen. This pathway may help explain why some people naturally have reduced Alzheimer’s risk. Sat, 22 Nov 2025 13:02:52 EST https://www.sciencedaily.com/releases/2025/11/251122044335.htm https://www.sciencedaily.com/releases/2025/11/251118220052.htm Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The treatment restored memory and reduced inflammation in rats, while also proving non-toxic and able to cross the blood–brain barrier. Because it’s far simpler and potentially cheaper than existing drugs, researchers are now pursuing partnerships to begin human trials. Wed, 19 Nov 2025 10:46:50 EST https://www.sciencedaily.com/releases/2025/11/251118220052.htm https://www.sciencedaily.com/releases/2025/11/251117095652.htm Researchers developed a new nano-micelle formulation, CBD-IN, that finally gets CBD into the brain effectively. In mice, it relieved neuropathic pain quickly and didn’t cause the usual movement or memory side effects. Surprisingly, the pain relief didn’t use typical cannabinoid receptors, instead calming abnormal nerve activity more directly. The findings hint at new avenues for treating chronic pain and neurological diseases. Tue, 18 Nov 2025 00:26:39 EST https://www.sciencedaily.com/releases/2025/11/251117095652.htm